Resonant Capital Advisors LLC Has $1.03 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Resonant Capital Advisors LLC lifted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 34.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,300 shares of the company’s stock after purchasing an additional 4,464 shares during the quarter. Resonant Capital Advisors LLC’s holdings in DocuSign were worth $1,028,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Capital World Investors lifted its position in shares of DocuSign by 128.3% during the 1st quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock worth $608,853,000 after buying an additional 3,193,727 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of DocuSign by 20.3% during the 1st quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company’s stock worth $1,854,127,000 after buying an additional 2,917,683 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of DocuSign by 256.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,545,176 shares of the company’s stock worth $148,384,000 after buying an additional 1,831,001 shares during the last quarter. Norges Bank bought a new stake in shares of DocuSign during the 4th quarter worth $99,841,000. Finally, AQR Capital Management LLC lifted its position in shares of DocuSign by 147.4% during the 3rd quarter. AQR Capital Management LLC now owns 1,908,500 shares of the company’s stock worth $80,157,000 after buying an additional 1,136,948 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Allan C. Thygesen sold 7,680 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Teresa Briggs sold 499 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $52.99, for a total transaction of $26,442.01. Following the completion of the sale, the director now owns 6,169 shares of the company’s stock, valued at $326,895.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the sale, the chief executive officer now directly owns 111,767 shares of the company’s stock, valued at approximately $6,847,964.09. The disclosure for this sale can be found here. Over the last quarter, insiders sold 54,871 shares of company stock valued at $3,176,199. Company insiders own 17.80% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on DOCU shares. Wells Fargo & Company dropped their price objective on DocuSign from $55.00 to $45.00 and set an “underweight” rating for the company in a research report on Monday, February 5th. Royal Bank of Canada restated a “sector perform” rating and set a $59.00 price objective on shares of DocuSign in a research report on Friday, April 12th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $48.00 to $62.00 in a research report on Friday, April 12th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research report on Friday, April 12th. Finally, Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $49.00 to $64.00 in a research report on Tuesday, January 16th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $60.25.

DocuSign Trading Down 2.3 %

Shares of DOCU stock opened at $55.70 on Friday. The stock has a market cap of $11.44 billion, a price-to-earnings ratio of 154.73, a PEG ratio of 4.99 and a beta of 0.89. The stock has a 50-day moving average of $55.90 and a 200-day moving average of $52.12. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.06. The company had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. Sell-side analysts forecast that DocuSign, Inc. will post 0.86 earnings per share for the current year.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.